SNDL (NASDAQ:SNDL – Get Free Report) and ICU Medical (NASDAQ:ICUI – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.
Analyst Ratings
This is a breakdown of recent recommendations for SNDL and ICU Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SNDL | 1 | 1 | 1 | 0 | 2.00 |
| ICU Medical | 0 | 2 | 4 | 3 | 3.11 |
SNDL presently has a consensus price target of $5.00, suggesting a potential upside of 270.37%. ICU Medical has a consensus price target of $172.00, suggesting a potential upside of 6.53%. Given SNDL’s higher probable upside, equities research analysts clearly believe SNDL is more favorable than ICU Medical.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SNDL | $677.32 million | 0.51 | -$11.29 million | ($0.03) | -45.00 |
| ICU Medical | $2.23 billion | 1.81 | $730,000.00 | $1.85 | 87.28 |
ICU Medical has higher revenue and earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares SNDL and ICU Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SNDL | -1.19% | -1.02% | -0.85% |
| ICU Medical | 2.15% | 7.50% | 3.91% |
Volatility and Risk
SNDL has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.76, meaning that its share price is 24% less volatile than the S&P 500.
Institutional & Insider Ownership
96.1% of ICU Medical shares are held by institutional investors. 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
ICU Medical beats SNDL on 13 of the 15 factors compared between the two stocks.
About SNDL
SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
About ICU Medical
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Receive News & Ratings for SNDL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNDL and related companies with MarketBeat.com's FREE daily email newsletter.
